Continued cross-border co-operation will be essential for the development, distribution and uptake of vaccines, as well as for the safe and smooth resumption of international travel that vaccines may allow.
Build trust: address public concerns about vaccine safety, invest in education and build partnerships with civil society to tackle misinformation and disinformation
Increase supply: support measures to scale up manufacturing capacity
Bolster support for distribution: anticipate potential future bottlenecks –more support for personnel and infrastructure at the “delivery-to-patient” level for vaccine delivery and administration, plus logistics support for warehousing and distribution
Improve access: prioritise programmes targeting the spread of new variants, especially for the most vulnerable; increase supply to low- and middle-income countries through COVAX; and share excess doses as available
Learn from each other: share knowledge and good practices for safe travel
Improve consistency of travel rules: participate in agreed protocols and initiatives.